coIMMUNE’s core team is highly experienced with greater than 17 years of preclinical and clinical development of cell therapy products. coIMMUNE has centralized manufacturing model with distribution capabilities to clinical sites in the United States, Canada, Europe and Israel.
Eleven ISO 7 processing rooms for processing and aseptic fill/finish of cellular products.
Warehouse with inventory management and cycle counting systems.
Immunomonitoring multi-color flow cytometry capabilities to support studies of mechanism of action, discovery or validation of prognostic and predictive markers of disease.
Research laboratories with expertise in cellular immunology and molecular biology.
Biological material collection and logistics. Ability to maintain patient-specific cell therapy chain of identity.
Two quality control laboratories equipped to support environmental monitoring program, in-process and release testing of cellular product and genetic material-based products, stability programs, raw material testing and qualification. Expertise in novel method validation.
Equipment installation, qualification, calibration and validation programs.
On time delivery of cryopreserved product for administration.